Introduction
IPI - International Pharmaceutical Industry – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally. One of the main reasons why clients are using us is the extensive knowledge and reach we have built up over the years with our Editor, Editorial advisory board and market research. We do not just cover issues in one marketplace, but give you links into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. Whether you are looking to highlight your own expertise or looking for that natural partnership and alliance, IPI can help. Informative articles from prominent industry figures plus exciting opportunities through our website will give value to your marketing spend to a truly global audience. Both editorially and advertising, we listen to your needs [it’s not all one way traffic]. Creating awareness through the journal, website and event attendance, we will promote your expertise globally. We have established a strong presence in the Middle East, Latin America, Eastern Europe, Asia and Africa which are becoming increasingly important to the way the industry is moving forward in areas of Research and Development, Trials, manufacturing and Technology Transfer. Come and speak with us to see if we can help you and justify your marketing spend and promotional activity. We are confident that we can provide you with a good service and also keep you in touch with your potential clients.


LETS  FACE  IT  MEDIA  HAS, AND WILL ALWAYS  BE  THE  ONLY  TRUE MEANS  OF  COMMUNICATIONS.
Patricia Lobo MSc. PhD.
Managing Partner,
RSA Management Consulting

I have worked in the pharma sector for over 30 years after graduating in Chemistry, Microbiology and Biochemistry and gaining an external PhD in Biochemical Pharmacology and a business training course.
Video Blog
Your video here!
Francis P. Crawley  
is the Executive Director of the Good Clinical Practice Alliance-Europe (GCPA) and a WHO Expert in ethics. He is also a member of the Scientific Advisory Committee for the WHO-International Clinical Trials Registry Platform.
Rob Nichols
is the Director, Commercial Development at Phase Forward. He was an academic statistician running large international epidemiological dietary studies. He held the Chair of the Board of Directors of the Association of Clinical Data Managers.
Charles Horth
has worked in the life sciences industry for over 45 years with a career span from basic research to product development, diagnostics, pharmaceutical and clinical research, bio analytical services, bio process depelopment and consulting services.
T.S. Jaishankar
is the Chairman of The Confederation of Indian Phamaceutical Industry, a national body for Pharma Manufacturers of India. He was involved withe the Government of India to draft the National Pharma Policy in India.
Maha Al-Farhan
VP ClinArt International and holds the Chair of the GCC Chapter of the Association of Clinical Research Professionals. She was the Managing Director of the Middle East Clinical Research Organisation, and is well known in the region as a keen proponent of Good Clinical Practices.
Dr. Collin Miller
SVP Medical Affairs at Bio-Imaging, heads up the scientific over-sight within the company & provides consulting on trials in the muscular-skeletal arena. He has a gained a Fellowship of the ICR (UK) and has attained the UK recognition of a Chartered Scientist.
This site is run by Pharma Publications
World Courier
BMG Labtech
BioClinica
SUPPORTING THE INDUSTRY THROUGH COMMUNICATION
Lyofal
Envirotainer
Ludger
Nexxus
Encompassing Approaches for Valuation of Early Stage Life Sciences Technology – Pharmaceutical companies seeking partnering strategies to bolster pipelines and drive long-term revenues are increasingly looking towards earlier stage compounds and technologies. Valuations are essential components of effective life sciences partnerships, however owing to the perceived uncertainty and risk associated with early stage life sciences technology, early stage valuations are a contentious area of valuation practice. Stephen Mayhew of Kinapse Ltd explores why meaningful early stage valuations require new approaches that integrate complementary evaluation practices to build robust valuation outputs. More

Performing Automated Dynamic Light Scattering Using Plate Reader Technology
Dynamic light scattering (DLS) is a technique commonly used to measure the size of molecules in solution. However, traditional methods of DLS often prove extremely time-consuming and labour-intensive, as well as offering limited reliability and reproducibility. This article by Dr Thomas Jocks & Dr Dierk Roessner of Wyatt Technology Europe discusses the benefits of new plate reader technology, which has been developed to address the growing need for fast, automated and reliable DLS measurements. Advanced plate readers are revealed as the optimal instrument for applications where size, stability and aggregation of molecules are of interest. More

Current Status of the Transition from Paper to Electronic Regulatory Submissions in the European Union.
After many years of very slow progress, the last two years have seen a dramatic acceleration in the transition to electronic submissions; eCTD submissions are now accepted without paper in the EU centralised procedure, and more than 50% of EU national agencies are now accepting electronic submissions without paper. This article by Martin T. Moxham of iRegulatory Ltd summarises the current situation regarding acceptance of electronic regulatory submissions in the European Union. More

The Next Generation of Clinical Supply Shipment Monitoring
Management of cold chain clinical supplies presents sponsor companies with significant logistical challenges, especially considering the global nature of distribution to many less-developed regions and emerging markets. When investigational products are shipped, supplies are subject to various factors which may influence the way in which temperature-controlled shipping systems may operate. These variables include myriad external temperature ranges, supply routes, transit time, and stability of data and people. Nathan Kohner of Almac Group explains that a process for the efficient visibility of the success of temperature control increases detectability, and therefore reduces the risk factor. More

Blister machine technology in use for better compliance
According to a study from the University of London, after ten days 30 per cent of chronically ill people do not take their prescribed medication properly, and after four weeks every second patient struggles with compliance. To ensure consistent compliance, especially in the case of chronically ill and older people, 7x4 Pharma GmbH commenced a pilot project with the compulsory health insurance AOK Berlin in 2009 to supply patients with individually-packed blisters with their weekly medication. Oliver Naucke of Uhlmann Pac-Systeme GmbH explains the concept of - “7x4 Box - My week´s medicine”. More
IPI CURRENT ISSUE FEATURES
Editorial Advisory BoardEditorial Advisory Board
Editorial Advisory BoardEditorial Advisory BoardEditorial Advisory Board
Editorial Advisory BoardEditorial Advisory BoardEditorial Advisory BoardEditorial Advisory Board
Editorial Advisory BoardEditorial Advisory BoardEditorial Advisory Board
Editorial Advisory BoardEditorial Advisory Board
Editorial Advisory Board
Editorial Advisory BoardEditorial Advisory Board
International Pharmaceutical Industry
Caprotec
Nova
Swiss World Cargo
International Pharmaceutical Industry
Vaccibody
Current Pulication
Patricia Lobo
Click to view
Spring
edition
Newsletter sign-up